Stay updated on Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer

Sign up to get notified when there's something new on the Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-04-26T03:15:10.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page has been updated to include new information about ovarian cancer and a new revision number, while significant details about a Phase 3 study and its criteria have been removed.
    Difference
    7%
    Check dated 2025-04-18T22:15:46.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-04T15:52:39.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.14.3, replacing the previous version 2.14.2.
    Difference
    0.0%
    Check dated 2025-03-28T05:21:33.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.5%
    Check dated 2025-03-06T13:24:38.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a new version (v2.14.2) of the NLM-NCBI services and products, indicating improvements or changes from the previous version (v2.14.0). Additionally, there is a notice about heavy traffic affecting performance and availability.
    Difference
    0.5%
    Check dated 2025-02-07T00:42:33.000Z thumbnail image

Stay in the know with updates to Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer

Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer page.